Max Character Limit 45

Max Character Limit 45

Max Character Limit 460 - error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto.

• rror sit voluptatem accusantium doloremque laudantium, totam rem aperiam
• rem aperiam, eaque ipsa quae ab illo
• illo inventore veritatis et quasi architecto sed ut perspiciatis unde omnis voluptatem

Challenges, Risks and Strategies for Biologic Drug Substance Manufacturing

ORC International’s research study revealed that demand forecasting is a significant challenge for biopharmaceutical companies when planning biologic drug substance production. Among the key unmet needs expressed by executives interviewed in the report is for greater capacity among CDMOs and greater flexibility in manufacturing processes. Biopharma organizations are turning more frequently to CDMOs for their deep expertise in biologic production, their use of specialized technologies and their flexible manufacturing processes.

Download and read Patheon’s perspective to the ORC study “Challenges, Risks and Strategies for Biologic Substance Manufacturing” and learn how Patheon’s new suite of biomanufacturing solutions provides both flexible and scalable capacity to biopharma organizations, thereby helping them speed time to market while mitigating risks from demand forecast inaccuracy.